Jorge Garcia Condado and Jesus M Cortes. NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer’s disease. Alzheimer’s Dement. 2023 [pdf] INTRODUCTION: BrainAge models based on neuroimaging data have diagnosticclassification power but have replicability issues due to site and patient variability. Brain Age models trained on neuropsychological tests could help distinguish stable mild cognitive impairment (sMCI) from progressive MCI(pMCI) to Alzheimer’s disease(AD). METHODS: A linear regressor Brain Age […]